^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PBCAR19B

    i
    Other names: PBCAR19B, Allogeneic Anti-CD19 CAR T cells, Next Generation CD19 Stealth Cell Candidate, PBCAR 19B, PBCAR-19B
    Associations

    News

    Trials
    Company:
    Precision BioSci
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    5ms
    Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies (clinicaltrials.gov)
    P1, N=13, Completed, Precision BioSciences, Inc. | Recruiting --> Completed | N=24 --> 13
    Trial completion • Enrollment change
    |
    CD19 (CD19 Molecule)
    |
    azercabtagene zapreleucel (PBCAR0191) • PBCAR19B